Saudi-listed Almajed Oud Co. has signed a non-binding offer to acquire a portfolio of healthcare, beauty, and retail businesses across the GCC, signaling consolidation in the regional medical aesthetics and pharmaceutical supply chain. The deal, valued at SAR 392 million, includes stakes in companies operating in Saudi Arabia, UAE, Bahrain, Qatar, and Oman, offering overseas buyers and distributors a potential new channel partner for aesthetic products and clinic supplies in the Gulf market.
Deal structure and valuation
The target group includes Al Safa Pharmaceuticals and Medical Supplies (100% stake in Saudi Arabia), Natural Touch (Saudi business line), Safa Al Khaleej Trading LLC (100% in UAE), The Beauty Secrets W.L.L (80% in Bahrain), Wahat Alsafa for Trading (100% in Qatar), and Al Safa National Investment (50% in Oman). The enterprise value is SAR 392 million, subject to adjustments for net debt estimated at SAR 224 million as of December 31, 2025. Consideration will be a mix of cash and newly issued Almajed Oud shares, with the share price set at SAR 151.01 based on the 90-day volume-weighted average through June 11, 2026.
Regulatory and channel signals
The transaction remains preliminary and non-binding, with no assurance of completion. It requires approvals from Saudi Arabia's General Authority for Competition (GAC), Capital Market Authority (CMA) for share issuance, Tadawul for listing, and shareholder approval for capital increase. The six-month exclusivity period and due diligence process indicate serious intent, but the deal could be restructured or terminated. For overseas aesthetic device and injectable suppliers, this signals potential consolidation of distribution channels in the GCC, as Almajed Oud may integrate beauty retail and pharmaceutical logistics across multiple markets.
What buyers should watch
Importers and distributors of medical aesthetics products should monitor this deal for potential shifts in GCC market access. Almajed Oud's acquisition of pharmacy, beauty retail, and trading entities could create a unified platform for product distribution, clinic supply, and retail sales. If completed, the combined entity may seek partnerships with international brands for aesthetic devices, injectables, and skincare lines. The involvement of entities like Natural Touch and The Beauty Secrets suggests a focus on both clinical and retail beauty channels, relevant for suppliers targeting the Gulf's growing medical aesthetics market.
Source: Read the original report | Published: June 14, 2026